Slr Investment Corp   (SLRC)
Other Ticker:  
Price: $15.2600 $0.12 0.793%
Day's High: $15.26 Week Perf: 1.73 %
Day's Low: $ 15.10 30 Day Perf: 5.46 %
Volume (M): 134 52 Wk High: $ 16.09
Volume (M$): $ 2,037 52 Wk Avg: $14.77
Open: $15.17 52 Wk Low: $13.48

 Market Capitalization (Millions $) 828
 Shares Outstanding (Millions) 54
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 19
 Cash Flow (TTM) (Millions $) -30
 Capital Exp. (TTM) (Millions $) 0

Slr Investment Corp

   Company Address: 500 Park Avenue New York 10022 NY
   Company Phone Number: 993-1670   Stock Exchange / Ticker: NASDAQ SLRC
   SLRC is expected to report next financial results on February 27, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

The Aes Corporation

AES Corp Records Slight Revenue Decline in Q2 2022, Compared to Last Year's Financial Results

In the constantly evolving world of the stock market, it's important to analyze and evaluate the financial performance of companies. Today, we'll be taking a closer look at The Aes Corporation and the recent developments in their second quarter of 2022.
While The Aes Corporation may have reported a loss of $-0.06 per share, it's worth highlighting the considerable improvement compared to the previous year's loss of $-0.27 per share. This indicates that the company's management has made significant strides in mitigating losses and improving their financial standing. Furthermore, it's worth noting that the earnings per share fell from $0.21 in the preceding reporting period, but it is important to keep in mind that EPS can fluctuate due to various factors.

Masco Corporation

Masco Corporation Faces Dip in Revenue and Earnings Despite Sequential Bottom-line Growth in Latest Fiscal Period

Masco Corporation, a leading manufacturer of building products and home improvement solutions, recently released its financial results for the most recent fiscal period. The company's bottom-line showed a slight decrease of -1.69% to $1.16 per share compared to $1.18 per share in the same period last year. However, it witnessed a significant growth of 28.89% from $0.90 per share in the prior quarter.
On the revenue front, Masco Corporation experienced a decline of -9.566% to $2.13 billion compared to $2.35 billion in the same quarter a year ago. However, sequentially, the company's revenue advanced by 7.479% from $1.98 billion. This suggests that the company has been able to generate better results in the most recent quarter despite a challenging environment.

Fgi Industries Ltd

First Quarter 2023 Earnings Reveal Major Revenue Decline

Fgi Industries Ltd, a Renewable Energy Services and Equipment company, recently declared disappointing financial results for the first quarter of 2023. The company's Revenue fell by a significant -37.666% to $27.16 million, and they posted a net loss per share to $-0.03, in proportion to $0.05. This is a significant decline compared to their preceding financial reporting period, where Income per Share was $0.07 per share, and Revenue deteriorated by -14.558% from $31.79 million.
Furthermore, the company's net shortfall was $-0.303 million this quarter, rather than the zero gain they recorded for the same financial reporting period a year before. Such statistics raise several questions regarding the future of Fgi Industries Ltd.
First and foremost, the decline in Revenue is a significant red flag. This statistic alone can be enough to set alarm bells ringing around shareholders and investors alike. As the company is involved in Renewable Energy Services and Equipment, it is essential to determine why Revenue has fallen and possibly predict whether this trend will continue.

Cullinan Oncology Inc

Renewable Energy Innovator Cullinan Oncology Inc Faces Operating Shortfall of $62.7 Million in Q1 2023

Cullinan Oncology Inc is a biotechnology company focused on developing targeted cancer therapies. With headquarters in Cambridge, Massachusetts, USA, the company was founded in 2017 and went public in 2020. Cullinan Oncology Inc operates in the Renewable Energy Services and Equipment industry, offering innovative treatments for cancer patients. The company is known for its innovative technologies in the field of oncology and has achieved great milestones in the industry.
Recently, the Renewable Energy Services and Equipment industry consultants have begun scrutinizing the company's first quarter of 2023 performance. Presently, these consultants have monitored an operating shortfall of $-62.756 million from the CGEM, which hasn't recorded any revenue so far for the respective January to March 31, 2023, quarter. The consultants advise to frame the financial first quarter of 2023 outcome, at the prevailing instance of the business. Currently, it is easy to correlate the operating shortfall of the first quarter of 2022, which came in at $-32.657 million. On the quest to prompt the lucrative revenue sources, entities frequently undergo uncommonly choppy stints. May be one of these, is the financial span ending March 31, 2023, where the deficit has extended to $-58.141 million.
In the coming days, Cullinan Oncology Inc is expected to report its next financial results on May 15, 2023. The company's income per employee fell on a trailing twelve-month basis to $31,973,000, but the productivity of Cullinan Oncology Inc's 2 employees remained above the company average. This is a reflection of the company's continued commitment to excellence and innovation.
The Renewable Energy Services and Equipment industry has seen Cullinan Oncology Inc achieve the highest income per employee. Meanwhile, Cullinan Oncology Inc's overall ranking has deteriorated compared to the fourth quarter of 2022, from $31,973,000. This may be attributed to the unforeseeable challenges in the industry or the choppy period experienced by entities in the quest to prompt the lucrative revenue sources. However, considering the milestones achieved by Cullinan Oncology Inc as a biotechnology company, such challenges may be surmounted shortly.

Babcock And Wilcox Enterprises Inc

Babcock And Wilcox Enterprises Inc Experiences Further Diminishing Returns in Fiscal First Quarter of 2023

As a financial journalist, it is my job to interpret the financial results of the companies and present them to the public in a concise and informative manner. In this article, I will be discussing the financial results of Babcock and Wilcox Enterprises Inc for the fiscal year ending in the first quarter of 2023.
The company has recorded a cumulative net loss of $-30 million during this 12-month period, resulting in a negative return on investment of -5.22%. This indicates that the company is not currently profitable and has not been able to generate a positive return for its investors.



About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com